IP Library Granted Patent US 12,370,290
Granted Patent B2
US 12,370,290 · App. 18/537,336 · Granted Jul 29, 2025

3D-printed scaffolds of peptide conjugate polymer

Inventors: Lesley W. Chow (Bethlehem, PA); Hannah L. Dailey (Neshanic Station, NJ); Hafiz Busari (Greenville, SC); Peter Schwarzenberg (Fountain Hill, PA); Katherine Hudson (Hopkinton, MA)
Assignee: Lehigh University
A61L27/54A61L27/18A61L27/58B29C64/106B33Y10/00B33Y70/00B33Y80/00A61L2430/02A61L2430/06A61L2430/10A61L2430/24B29K2067/00B29K2089/00B29L2031/7532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,370,290
App. No.
18/537,336
Granted
Jul 29, 2025
Kind
B2
Abstract

Described herein is a 3D-printed scaffold comprising a peptide-polymer conjugate, the peptide-polymer conjugate having the structure: X—Y—Z—Y—X, wherein X is a biologically active peptide, Y is a linker moiety, and Z is a biocompatible and biodegradable polymer.

Claims (25)

1. An implantable scaffold comprising a peptide-polymer conjugate, the peptide-polymer conjugate comprising:

a biologically active peptide;

a linker; and

a biocompatible polymer,

wherein the linker comprises a maleimide functionalized compound and at least one of a hydroxyl-reactive group, an aromatic group, or an aliphatic chain.

2. The implantable scaffold according to claim 1 , wherein the biocompatible polymer is a polyester.

3. The implantable scaffold according to claim 2 , wherein the polyester comprises a cyclic ester.

4. The implantable scaffold according to claim 3 , wherein the cyclic ester is a lactone.

5. The implantable scaffold according to claim 4 , wherein the lactone is selected from: caprolactone, t-butyl caprolactone, zeta-enantholactone, deltavalerolactones, monoalkyl-delta-valerolactones, nonalkyl-epsilon-caprolactones, dialkyl-epsilon-caprolactones, trialkyl-epsilon-caprolactones, monomethyl-epsilon-caprolactones, monoethyl-epsilon-caprolactones, monohexyl-epsilon-caprolactones, beta-lactones, gamma-lactones, dilactones, and a combination of two or more thereof.

6. The implantable scaffold according to claim 5 , comprising a poly(caprolactone) having a molecular weight ranging from about 10,000 to about 18,000 g/mol.

7. The implantable scaffold according to claim 1 , further comprising a high molecular weight polymer blended with the peptide-polymer conjugate.

8. The implantable scaffold according to claim 1 , wherein the maleimide functionalized compound comprises an isocyanate group.

9. The implantable scaffold according to claim 8 , wherein the linker is formed from p-maleimidophenyl isocyanate.

10. The implantable scaffold according to claim 1 , wherein the biologically active peptide is formed with a thiol-functionalized peptide.

11. The implantable scaffold according to claim 10 , wherein the thiol-functionalized peptide is a cysteine containing peptide.

12. The implantable scaffold according to claim 1 , wherein the biologically active peptide comprises about 5 to about 30 amino acids.

13. The implantable scaffold according to claim 1 , wherein the implantable scaffold comprises a plurality of first fibers and a plurality of second fibers, the plurality of first fibers comprising the peptide conjugate polymer.

14. The implantable scaffold according to claim 13 , wherein the plurality of first fibers further comprises a second polymer, the second polymer comprising a polyester polymer.

15. The implantable scaffold according to claim 13 , wherein the second polymer is a poly(caprolactone).

16. The implantable scaffold according to claim 14 , wherein the first polymer and the second polymer are present in a weight ratio of about 1:2 to about 5:1.

17. The implantable scaffold according to claim 13 , wherein the plurality of first fibers and the plurality of second fibers form an intersecting pattern comprising a cross-hatch geometry.

18. A method of forming an implantable scaffold comprising:

a) 3D-printing a plurality of first fibers in a first direction to form a first layer;

b) 3D-printing a plurality of second fibers in a second direction atop the first layer to form a second layer, wherein the first and second directions are different; wherein at least one of the first fibers or the second fibers comprise the peptide-polymer conjugate according to claim 1 .

19. The method according to claim 18 , wherein the 3D-printing of step a) includes 3D-printing a first ink composition to form the plurality of first fibers, the first ink composition comprising a volatile solvent and the peptide-polymer conjugate; and wherein the 3D-printing of step b) includes 3D-printing a second ink composition to form the plurality of second fibers, the second ink composition comprising a volatile solvent and the peptide-polymer conjugate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2023
From: CHOW, LESLEY W.; DAILEY, HANNAH L.; BUSARI, HAFIZ; SCHWARZENBERG, PETER; HUDSON, KATHERINE
To: LEHIGH UNIVERSITY
Reel/Frame 065848/0112 →
Continuity (3)
Continuation 16632992
Provisional Application 62535955 · Jul 23, 2017
Related Publication 20240115771A1 · Apr 11, 2024
References Cited (17)
US 7968026B1 · Teoh et al. · 2011 [cited by applicant]
US 8071007B1 · Teoh et al. · 2011 [cited by applicant]
US 11839699B2 · Chow · 2023 [cited by examiner]
WO WO2016176444A1 · 2016 [cited by applicant]
Lesley W. Chow et al.: “Peptide-Directed Spatial Organization of Biomolecules in Dynamic Gradient Scaffolds”, Adv. Healthcare Mater. 2014, 3, 1381-1386 (Year: 2014). [cited by examiner]
Joao F M Ribeiro et al.: “Structural monitoring and modeling of the mechanical deformation of three-dimensional printed poly( -caprolactone) scaffolds”, Biofabrication 9 (2017) 025015 (Year: 2017). [cited by examiner]
International Search Report and Written Opinion issued for PCT/US2018/043262, mail date Oct. 15, 2018, pp. 1-14. [cited by applicant]
Chow et al. “Peptide-directed spatial organization of biomolecules in dynamic gradient scaffolds,” Advanced Healthcare Materials, Feb. 24, 2014 (Feb. 24, 2014), vol. 3, pp. 1381-1386. [cited by applicant]
Ribeiro et al. “Structural monitoring and modeling of the mechanical deformation of three-dimensional printed poly(E-caprolactone) scaffolds,” Biofabrication, May 11, 2017 (May 11, 2017), vol. 9, pp. 1-13. [cited by applicant]
He et al. “An Investigation of the Behavior of Solvent based Polycaprolactone ink for Material Jetting,” Sci Rep, Feb. 12, 2016 (Feb. 12, 2016), vol. 6, pp. 1-10. [cited by applicant]
Chow, L.W. “Chapter 3: Electrospinning Functionalized Polymers for Use as Tissue Engineering Scaffolds,” Biomaterials for Tissue Engineering: Methods and Protocols, Methods in Molecular Biology, Apr. 21, 2018 (Apr. 21, … [cited by applicant]
Hansske Felix et al : “Via precise interface engineering towards bioinspired composites with improved 3D printing processability and mechanical properties” Journal of Materials Chemistry. B, vol. 5, No. 25, May 30, 2017… [cited by applicant]
Chow et al. “Peptide-directed spatial organization of biomolecules in dynamic gradient scaffolds,” Advanced Healthcare Materials, vol. 3, No. 9, Sep. 1, 2014 (Sep. 1, 2014), pp. 1381-1386. [cited by applicant]
Joao F M Ribeiro et al : “Structural monitoring and modeling of the mechanical deformation of three-dimensional printed poly ([epsilon] -caprolactone) scaffolds”, Biofabri Cation, vol. 9, No. 2, May 11, 2017 (May 11, 20… [cited by applicant]
A. Gloria et al. : “Three-dimensional Poly(e-caprolactone)bioactive scaffold with controlled structural and surface properties”, Biomacromolecules 13. 11 (2012): 3510-3521 (Year: 2012). [cited by applicant]
Harrison et al. “Modular and Versatile Spatial Functionalization of Tissue Engineering Scaffolds through Fiber-Initiated Controlled Radical Polymerization,” Adv Fune! Mater, Aug. 17, 2015 (Aug. 17, 2015), vol. 25. pp. 5… [cited by applicant]
Trachtenberg et al. “Open-source three-dimensional printing of biodegradable polymer scaffolds for tissue engineering, ” J Biomed Mater Res A, Dec. 1, 2014 (Dec. 1, 2014), vol. 102, pp. 4326-4335. [cited by applicant]